首页|期刊导航|中国神经再生研究(英文版)|Dose optimization of intrathecal administration of human umbilical cord mesenchymal stem cells for the treatment of subacute incomplete spinal cord injury
中国神经再生研究(英文版)2022,Vol.17Issue(8):1785-1794,10.
Dose optimization of intrathecal administration of human umbilical cord mesenchymal stem cells for the treatment of subacute incomplete spinal cord injury
Dose optimization of intrathecal administration of human umbilical cord mesenchymal stem cells for the treatment of subacute incomplete spinal cord injury
摘要
关键词
effective dose/human umbilical cord mesenchymal stem cells/intrathecal implantation/ion channels/neurotransmitter receptors/spinal cord injury/subacute spinal cord injury/γ-aminobutyric acid type A (GABAA) receptorsKey words
effective dose/human umbilical cord mesenchymal stem cells/intrathecal implantation/ion channels/neurotransmitter receptors/spinal cord injury/subacute spinal cord injury/γ-aminobutyric acid type A (GABAA) receptors引用本文复制引用
Ting-Ting Cao,Huan Chen,Mao Pang,Si-Si Xu,Hui-Quan Wen,Bin Liu,Li-Min Rong,Mang-Mang Li..Dose optimization of intrathecal administration of human umbilical cord mesenchymal stem cells for the treatment of subacute incomplete spinal cord injury[J].中国神经再生研究(英文版),2022,17(8):1785-1794,10.基金项目
This work was supported by the National Key Research and Development Program of China,No.2017YFA0105401(to LMR),the National Natural Science Foundation of China,Nos.31671420 and 81602482(to MML)and a grant from the Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases. (to LMR)